Dose-Response Profile Of A Novel Anti-Interleukin-1 Therapeutic, Rytvela, For Prevention Of Preterm Birth.Tiffany Habelrih,Sarah-Eve Loiselle,France Cote,Xin Hou,Christiane Quiniou,Sylvain ChemtobREPRODUCTIVE SCIENCES(2021)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要